Friday, July 10, 2026

pharma · Primary Sclerosing Cholangitis (PSC) · No medical condition.

Dr. Falk Pharma

News and analysis for Dr. Falk Pharma on NovaPharmaNews — regulatory, clinical, and market coverage.

Leinenweberstraße 5, Freiburg im Breisgau, Baden-Württemberg 79108, DE HQ
399 Employees
EMA registrant Type
Company details
Status
Public
HQ
Leinenweberstraße 5, Freiburg im Breisgau, Baden-Württemberg 79108, DE
Employees
399
Programs
11
Drugs
15
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Dr. Falk Pharma — regulatory, clinical, and market coverage.

News and analysis for Dr. Falk Pharma on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Dr. Falk Pharma yet.

Back to company overview →